Robert F. Apple's most recent trade in Kazia Therapeutics Limited - ADR was a trade of 75,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kazia Therapeutics Ltd (ADR) | Robert F. Apple | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2026 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) |